Chronic Lymphocytic Leukemia — Proceedings from a Symposium Held in Partnership with the American Oncology Network
Hematologic Oncology Update
00:00
Case 2: fit 82‑year with TP53 mutation
For unmutated IGHV with TP53, Rogers favors continuous BTK for best PFS but tailors to fitness and patient preference.
Play episode from 21:18
Transcript
